U.S. markets close in 5 hours 29 minutes
  • S&P 500

    3,754.77
    -64.06 (-1.68%)
     
  • Dow 30

    30,569.59
    -459.72 (-1.48%)
     
  • Nasdaq

    10,906.66
    -271.24 (-2.43%)
     
  • Russell 2000

    1,682.38
    -36.99 (-2.15%)
     
  • Crude Oil

    106.74
    -3.04 (-2.77%)
     
  • Gold

    1,815.50
    -2.00 (-0.11%)
     
  • Silver

    20.32
    -0.42 (-2.02%)
     
  • EUR/USD

    1.0425
    -0.0019 (-0.18%)
     
  • 10-Yr Bond

    3.0240
    -0.0690 (-2.23%)
     
  • GBP/USD

    1.2168
    +0.0046 (+0.38%)
     
  • USD/JPY

    135.9380
    -0.6070 (-0.44%)
     
  • BTC-USD

    18,943.83
    -1,152.30 (-5.73%)
     
  • CMC Crypto 200

    405.47
    -26.00 (-6.03%)
     
  • FTSE 100

    7,122.81
    -189.51 (-2.59%)
     
  • Nikkei 225

    26,393.04
    -411.56 (-1.54%)
     

1 Green Flag for Eli Lilly Investors in 2022 -- and 1 Red Flag

·4 min read
1 Green Flag for Eli Lilly Investors in 2022 -- and 1 Red Flag
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Pharma giant Eli Lilly & Company (NYSE: LLY) has performed splendidly in the past year, leaving both the broader market and the pharmaceutical industry in the dust. Geopolitical tensions, which are already high, could escalate further and send Eli Lilly (along with the rest of the market) crashing. If we put these marketwide worries aside, though, there is at least one key reason why the future looks bright for Eli Lilly.